Anil P. Ranganath

CIK: 0001980144

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TMDX

TransMedics Group, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

TMDX
TransMedics Group, Inc.
Mar 2, 2026
Sale(S)
Direct
864 shares at avg. $139.12$120K
TMDX
TransMedics Group, Inc.
Nov 25, 2025
Exercise(M)
Direct
3K shares at avg. $93.88$282K
TMDX
TransMedics Group, Inc.
Nov 25, 2025
Sale(S)
Direct
3K shares at avg. $145.22$436K
TMDX
TransMedics Group, Inc.
Jun 9, 2025
Sale(S)
Direct
686 shares at avg. $139.80$96K
TMDX
TransMedics Group, Inc.
Feb 24, 2025
Award(A)
Direct
5.6K shares-

		Type	Shares	Price		Ownership
Mar 2, 2026	TMDX TransMedics Group, Inc.	Sale(S)	864	$139.12	$120,200	Direct
Nov 25, 2025	TMDX TransMedics Group, Inc.	Exercise(M)	3,000	$93.88	$281,640	Direct
Nov 25, 2025	TMDX TransMedics Group, Inc.	Sale(S)	3,000	$145.22	$435,660	Direct
Jun 9, 2025	TMDX TransMedics Group, Inc.	Sale(S)	686	$139.80	$95,903	Direct
Feb 24, 2025	TMDX TransMedics Group, Inc.	Award(A)	5,634	-	-	Direct

1-5 of 5 transactions

About Ranganath Anil P.

Ranganath Anil P. (SEC CIK 0001980144) files insider reports with the SEC as Officer of TransMedics Group, Inc. (TMDX).

Signal8 holds 4 ownership filings by Ranganath Anil P., all Form 4s, filed between Feb 26, 2025 and Mar 4, 2026. Those filings report 5 transactions, from Feb 24, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ranganath Anil P.'s filings is in ANDOVER, MA.

Recent filings by Ranganath Anil P.

Mar 2, 2026: Open-market sale of TMDX shares (Form 4, code S).
Nov 25, 2025: Option exercise of TMDX shares (Form 4, code M).
Nov 25, 2025: Open-market sale of TMDX shares (Form 4, code S).
Jun 9, 2025: Open-market sale of TMDX shares (Form 4, code S).
Feb 24, 2025: Grant or award of TMDX shares (Form 4, code A).

Other insiders filing for TransMedics Group, Inc. (TMDX)

Araujo Fernando N.
Weill David, Director
TOBIN JAMES R, Director
Corcoran Nicholas
Hernandez Gerardo, Chief Financial Officer
Hassanein Waleed H, President & CEO

How to read Form 4 transaction codes